Corona Remedies IPO Listing Monday: GMP Jumps 31% Ahead of Debut

• Corona Remedies IPO is scheduled to list on BSE and NSE on Monday, December 15.
• The IPO's Grey Market Premium (GMP) increased to 31% (Rs 330), suggesting a strong market debut.
• The public subscription for the IPO, open from December 8-10, was oversubscribed 144.54 times.
• The Rs 655.37-crore IPO had a price band of Rs 1,008 to Rs 1,062 per share.
• Corona Remedies is an Ahmedabad-based pharma company focusing on women's healthcare, cardio-diabeto, pain management, and urology.

Why It Matters: Corona Remedies IPO's high GMP signals strong investor demand and potential listing gains.